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Introduction 
INTRODUCTION
India with long coastline, has one of the major important coastal agro ecosystem that 
supports livelihood of several million people. However this system is highly fragile.  Due to the 
rapid ecological changes during the past decade many zoonotic diseases have emerged and 
resulted in epidemics leading to significant morbidity and mortality in humans. Leptospirosis is 
one among them.29
 Leptospirosis  is  a  zoonotic  infection  caused  by  the  spirochaete  of  the  Genus 
Leptospira. It affects humans worldwide, in both urban and rural areas and in temperate and 
tropical climates.46   Pathogenic leptospires live in the kidney of natural hosts, predominantly 
mammals and are excreted with the urine into the environment where they survive for several 
months in humid, warm and slightly alkaline conditions. Humans are accidental hosts and are 
infected by contact with an environment contaminated by urine of shedder hosts such as 
rodents, cattle and dogs.90
 The route of infection is through abraded skin and mucus membranes. Pathogenic 
leptospires rapidly invade the bloodstream and causes disruption of the integrity of the cell 
membrane of the endothelial cells lining the blood vessels in all parts of the body. Capillary 
leakage  and  hemorrhages  occur  in  all  the  organs  and  tissues,  particularly  the  lungs, 
omentum and pericardium. Ischaemia from damage to blood vessels in the renal cortex leads 
to renal tubular necrosis, particularly of the proximal convoluted tubules. This may lead to 
renal failure that can be fatal. Liver cell necrosis caused by ischaemia and the destruction of 
hepatic architecture leads to the characteristic jaundice of the severe type of leptospirosis. 
Blood  clotting  mechanisms  are  affected  by  liver  failure,  aggravating  the  haemorrhagic 
tendencies.91   Thus the  clinical  spectrum of  leptospirosis  is  very wide  with  mild  anicteric 
presentation  at  one end to  severe  leptospirosis  with  severe  jaundice  and multiple  organ 
involvement on the other end.29
 The clinical presentation of leptospirosis is a biphasic illness. The first phase of the 
disease  is  commonly  referred  to  as  the  septicemic  phase.  It  is  characterised  by  fever, 
headache,  myalgia,  conjunctival  congestion and a host  of  non-specific  features that  may 
include mild cough, lymphadenopathy, rash, anorexia, nausea, and vomiting. This phase is 
followed by a brief afebrile period of variable duration that, in turn, is followed by the immune 
phase  of  illness.  The  common  organs  involved  during  immune  phase  are  the  liver  and 
kidneys.  Both  organ  derangements  are  reversible.  The  severe  form  of  leptospirosis, 
commonly known as “Weil’s disease”, is characterised by a fulminant course with rapid onset 
of hepatic and renal failure and high mortality.3
 Eventhough it is a potentially serious disease it can be treated. Early diagnosis and 
appropriate treatment will halt the progression of the disease and reduces the mortality and 
morbidity of this zoonotic infection.
Its  symptom mimicks  many other  diseases  like  dengue,  viral  hepatitis,  meningitis, 
influenza and viral haemorrhagic fevers.Unless a high index of suspicion is maintained and 
laboratory  assistance  sought,  clinical  diagnosis  is  impossible,  in  majority  cases  and 
leptospirosis will be missed in all but a few instances.2
In an endemic area, suspecting leptospirosis on clinical grounds should not be very 
difficult.  It  is  therefore  necessary  to  increase  the  awareness  and   the  knowledge  of 
leptospirosis, as it is a  public health threat
Dual infection of leptospirosis with other diseases such as Dengue39 and Hepatitis B40 
have also been reported in places where these diseases are endemic and leptospirosis may 
be  overlooked  in  such  cases.  Recognition  of  leptospirosis  is  especially  important  since 
antimicrobial agents can reduce its severity and duration.85  A presumptive bedside diagnosis 
with serological confirmation may be made, only if a high index of suspicion is maintained.40 
Failure  to  identify  leptospirosis  in  these patients  will  result  in  high  mortality  rate  for  this 
infection.
Hence this study was conducted with the objective of correlating different laboratory 
parameters including radiological features in leptospirosis so that a quick clinical suspicion 
can be made out and diagnosed early for initiating appropriate treatment and for a better 
outcome.
Review of Literature
REVIEW OF LITERATURE
HISTORY
            Leptospirosis is a zoonosis of ubiquitous distribution caused by infection with 
pathogenic leptospira species.46
             Adolf Weil described leptospirosis as a disease entity in 1886. His name is still 
attached to a serious form of leptospirosis called Weil’s disease. traditionally attributed to rat 
transmitted  infection,  caused  by  the  serovars  icterohaemorrhagiae and  copenhageni.  At 
present, it is preferable to refer all leptospiral infections as leptospirosis regardless of clinical 
symptoms and signs. Goldsmidt first used the term Weil’s disease in 1887. In 1907 Stimson 
demonstrated by silver staining the presence of clumps of spirochaetes that caused weil’s 
disease  in  the  kidney  tubules  of  a  patient  who  reportedly  died  of  yellow  fever.  The 
spirochaetes had hooked ends and Stimson named them Spirochaeta interrogans because of 
their resemblance to question mark. Unfortunately this sentil observation was overlooked for 
many years.20
             The etiology of leptospirosis was demonstrated independently in 1915 in Japan and 
Germany. In Japan, Inada and Ido detected both spirochaetes and specific antibodies in the 
blood  of  Japanese  miners  with  infectious  jaundice.  In  Germany,  two  groups  of  German 
physicians studied German soldiers afflicted by “French disease” in the trenches of Northeast 
France. Uhlenhuth and Fromme and Hubner and Reiter detected spirochaetes in the blood of 
guinea pigs inoculated with the blood of infected soldiers46.
               The first  isolate made in 1917 from a patient in Japan with  jaundice and 
haemorrhagic  manifestations  was  named  as  Icterohaemorrhagiae.  Subsequently  other 
members of serogroups were isolated in various places of the world from different animals 
reservoir hosts.  Inada identified Leptospira  hebdomadis carried by the field mouse as the 
causative agent for the nonicteric syndrome the “7 day fever”.20
ALTERNATIVE NAMES FOR LEPTOSPIROSIS
              Autumnal fever, Cane field fever, Canicola fever, Field fever, Haemorrhagic jaundice, 
Mud  fever,  Rice  Field  fever,  Seven  Day  fever,  Bushy-Creek  fever,  Cane  Cutter  fever, 
European Swamp fever,  Fort  bragg fever,  Pea Pickers Disease,  Spirochaetosis,  Stuttgart 
disease, Swamp fever, Swineherd disease, Wycon fever and Weil’s disease.
ETIOLOGY
              Leptospirosis is an infectitious disease caused by pathogenic bacteria called 
leptospires. Leptospires are spirochaetes belonging to the Order Spirochaetales and Family 
Leptospiraceae.
DISTRIBUTION
              Leptospirosis occurs worldwide but is most common in tropical and subtropical areas 
with high rainfall. The disease is found mainly wherever humans come into contact with urine 
of infected animals or a urine polluted environment.94
MORPHOLOGY
             Leptospires are cork screw shaped bacteria which differ from other spirochaetes by 
the presence of end hooks.94   Leptospires are long (6-20µm), thin (approximately 0.1µm)22 
tightly  coiled  spirochaetes,  which  are  characterised  by  very  active  bending  and  rotating 
motility.  Usually one or both ends are bent or hooked but straight forms also occur.  The 
helical  amplitude  is  approximately  0.1µm-  0.15µm  and  the  wavelength  is  approximately 
0.5µm.21   Two axial filaments (periplasmic flagella) with polar insertions are located in the 
periplasmic space.  The structure of  the flagellar  proteins is  complex.88  Morphologically all 
leptospires  are  indistinguishable,  but  the  morphology  of  individual  isolates  varies  with 
subculture in vitro and can be restored by passage in hamsters.16  Leptospires  pass through 
bacteriological filters of average pore diameter 0.2µm.5
              Leptospires have a typical double membrane structure in common with other 
spirochaetes  in  which  the  cytoplasmic  membrane  and  peptidoglycan  cellwall  are  closely 
associated and are overlain by an outer membrane. Leptospiral lipopolysaccharides has a 
composition similar to that of other gram negative bacteria but has lower endotoxic activity.74
              Though there are more than 260 serovars41  of leptospira many of them are cross 
reactive due to the overlapping of the antigenic structure. Two types of antigen have been 
identified. The surface antigen contains protein polysaccharide and is serovar specific, while 
the somatic antigen contains genus specific lipopolysaccharide.19  The outer membrane of the 
organism  is  a  potent  immunogen  and  is  the  target  for  the  immunoglobulin-  complement 
mediated bactericidal action.
               Leptospira  have a thermolabile oxygen stable, soluble hemolysin and various other 
enzymes like catalase, lipase, oxidase, peroxidase and hyaluronidase. Presence of endotoxin 
has also been shown in certain serovars. Neither bacteriophages nor plasmids have been 
isolated from leptospires.  Leptospires are not known to produce bacteriocins.21
CLASSIFICATION
               The genera  Leptospira,  Leptonema and Turneria  belong to  the family of 
Leptospiraceae.  The  families  Leptospiraceae  and  Spirochaetaceae  (genera  Borrelia  and 
Treponema)  make  up  the  Order  Spirochaetales.  The  classification  and  nomenclature  of 
Leptospira is complex but presently two different classification systems are being used.61
1. Serologic Classification [Based on antigenic determinants]
2. Genotypic Classification [Based on genetic criteria]
1. Serologic classification
Prior  to1989  the  genus  leptospira  was  divided  into  two  species,   L.  interrogans 
comprising of all pathogenic strains and L. .biflexa containing the saparophytic strains isolated 
from  the  envoirrnment  .[Faine  et  al.,  1982,  Johnson  R.  C.  et  al,  1984].  L.biflexa was 
differentiated from L.  interrogans by the growth  of  the former at  13°C and growth in  the 
presence of 8-azaguanine [225µg/ml ] and by the failure of L.biflexa to form spherical cells in 
1M Nacl.20
             Both L. interrogans and L. biflexa are divided into numerous serovars defined by 
agglutination after cross absorption with homologous antigen (Dikken H et al., 1978).15,35,41 
Serovars are considered distinct if more than 10% of the homologous titre remains in atleast 
one of the two antisera on repeated testing.31   Over 60 serovars of L.  biflexa and over 200 
serovars of L.  interrogans  are recognised.31,32   Serovars that are antigenically related have 
traditionally been grouped into serogroups. Serogroups have no taxonomic standing, but the 
concept has proved useful for epidemiological purposes.
2. Genotypic classification
The phenotypic classification of Leptospires was replaced by a genotypic one, in which 
17 genemospecies include all  serovars of   Leptospira.9,67,95  DNA sequences of genes are 
attractive targets for phylogenetic studies. The sequence of the rrs gene, coding for 16s r 
RNA, is the most commonly used and accepted for studying genetic relationships (Perolat et 
al., 1998).65
               A classification system based on genetic traits should ideally allow subspecies 
characterisation. Typing methods should be simple to perform and give reliable results if they 
are to meet the needs of clinical and epidemiological practice.
                A variety of methods of genetic analysis have become available in the last few 
years. The use of quantitative DNA-DNA hybridisation to measure DNA relatedness among 
leptospiral strains is the reference method of allocating strains to species.94
                The genemospecies of leptospira do not correspond to the previous two species (L. 
interrogans and L. biflexa) and indeed, pathogenic and non-pathogenic serovars occur within 
the same species.61
                 Species based on genetic analyses are listed together with the serogroups most 
commonly present in these species.Neither serogroup nor serovar reliably predicts the true 
species of Leptospira.61
EPIDEMIOLOGY
(a) Agent factors 
(i) Source of  Infection 
           Leptospira are excreted in urine of infected animals for a longtime, often for an entire 
lifetime in cases of rodents.63  Their alkaline urine pH and  renal tissue pH are favourable for 
the organism’s survival, permitting permanent colonising and urinal sheding.8
(ii) Animal reservoirs 
Animals,  including  humans  can  be  divided  into  maintenance  hosts  and  accidental 
(incidental) hosts. A maintenance host is defined as a species in which infection is endemic, 
usually transferred from animal to animal by direct contact. Infection is usually acquired at an 
early age and the prevalence of chronic excretion in the urine increases with the age of the 
animal.  The  animal  hosts  are  not  symptomatic  and  do  not  develop  antibody  despite 
overhelming infection.23
Other animals (such as humans) may become infected by indirect contact with the 
maintenance host. Animals may be maintenance host of some serovar, but incidental host of 
others, infection with which may cause severe or fatal disease.
The most important maintenance hosts are small mammals such as rats and small 
rodents which may transfer infection to domestic farm animals, dogs and humans. Different 
rodent species may be reservoirs of distinct serovars,  but rats are generally maintenance 
hosts for serovars of the serogroup Icterohaemorrhagiae and mice are generally maintenance 
host for serogroup Ballum serovars fully. Domestic animals such as dairy cattle, pigs, dogs, 
sheep, cattle, goats, water buffalo also are maintenance hosts.61 Infections may spread from 
wild animals to domestic livestock and then to humans.60
(b) Host factors
Human infection is usually due to occupational exposure to the urine of infected animals.
(i) High risk groups
Agricultural workers
Such  as  rice  field  planters,  sugarcane  and  pineapple  field  harvestors,  livestock 
handlers,  labourers engaged in  canal  cleaning operations are subjected to exposure with 
leptospires which have reservoir in rodents, cattle, swine, sheep, goats etc.
Some other occupational groups are fishermen, sewer workers and all those persons 
who are liable to work in rodent infested environment.
Lorry drivers and Masons
As lorry drivers may use contaminated water to wash their vehicles and Masons may 
come  in  contact  with  the  organisms,  while  preparing  the  cement  and  sand  mixture  for 
construction work with contaminated water.
Leisure time activities such as swimming may also carry risks.
(ii)  Age and sex distribution
Males  suffer  more  frequently  from  leptospirosis  than  females  because  of  greater 
occupational exposure to infected animals and contaminated environment. Gender difference 
in susceptibility is not apparent under conditions where both men and women are at equal 
risk.  Leptospiral  infections  occur  more  frequently  in  persons  20-30  years  of  age  group. 
Leptospirosis  rarely  occurs  in  young  children  and  infants,  possibly  because  of  minimal 
exposure.29
(c) Environmental factors
Leptospirosis is acquired through contact with an environment contaminated by urine 
from  carrier  (reservoir)  or  infected  animal  or  by  handling  of  infected  animal  tissues.73 
Leptospirosis  shed  in  urine  can  survive  for  weeks  in  soil  and  water,  so  environmental 
contamination may reach high levels in areas where carrier animals frequently urinate. The 
association of poor housing, limited water supply, inadequate method of waste disposal, all 
combine to make the disease a significant risk for the poor population in both urban and rural 
areas.93
Seasonal variation:
Leptospirosis peak incidence occurs in the rainy season or flooding after heavy rains in 
tropical regions and the late summer to early fall in temperate regions.33,34,71,72
MODE OF TRANSMISSION
(a) Direct contact
Leptospira  can  enter  the  body  through  skin  abrasions  or  through  intact  mucous 
membrane by direct contact with urine or tissue of infected animal.
(b) Indirect contact:
Through the contact of broken skin with soil, water or vegetation contaminated by urine 
of infected animals.
Human to human transmission is rare. Man is usually a dead end host.11
CULTURAL CHARACTERISTICS
Leptospires are obligate aerobes. When cultivated in a suitable aerated medium at 
30ºC and an optimal pH of 7.2 to 7.6 their generation time varies from 7-12 hours and yields 
are 6 to 8×109 cells/ml. Leptospires cannot synthesise fatty acids de novo which is their main 
source of energy and carbon and also source for the cellular lipids. So in addition to long 
chain fatty acids, Vitamin B1, Vitamin B12 and ammonium salts(source for nitrogen) are also 
required for their growth. Leptospires incorporate purine bases but not pyrimidine bases into 
their nucleic acids and because of this they are resistant to the anti-bacterial activity of the 
pyrimidine analogue 5-Flurouracil.This compound is used in selective media for the isolation 
of leptospires from contaminated sources.19
Owing  to  the  inherent  toxicity  of  free  fatty  acids,  these  must  be  supplied  to  the 
leptospires either bound to albumin or in non toxic esterified form. Pyruvate enhances the 
initiation of  growth  of  the parasitic  leptospires.  Leptospires can survive  for  many days to 
months in wet soil and fresh water with the pH in a neutral range. In salt water the survival 
time is only few hours.19
CULTURE MEDIA
The  type  of  media  used  for  the  isolation  and  cultivation  of  leptospires  are  media 
enriched with rabbit serum or Bovine serum Albumin(BSA) and protein free media. Liquid 
media are necessary for growing the cultures for serological diagnosis of infections and for 
typing the isolates. Liquid media are converted to a semi solid form by the incorporation of 0.2 
percent agar and to the solid form by addition of 1% agar. Growth is readily initiated in these 
media and usually is easily visualised as one or more rings of dense growth several mm to 
cm below the surface of the medium, although a lack of rings of growth does not necessarily 
mean an absence of leptospires. Solid media are used for cloning the strains and for isolating 
leptospires from contaminated sources. Colonies in 1% agar are subsurface and become 
visible within 7-14 days.7
PATHOGENESIS
Once Leptospira gain entry in human body they spread through blood stream to all 
organs. Avirulent strains fail to multiply in the body and are removed from the blood in a day 
or two. Virulent leptospires multiply in the blood stream and in various organs and body fluids 
including  the  CSF.  The  organisms  at  this  stage  can  be  recovered  from  all  tissues 
(Leptospiremic stage) for 4-7 days. Leptospires lead to extensive endothelial injury resulting 
in  multiple  haemorrhages  throughout  the  body,  transudation  of  fluid  from  the  vascular 
compartment and hypovolemia.21
Agglutinating antibodies start appearing in the blood around the fifth day(Immune stage).55 
The organisms are then opsonized and removed from the blood by the reticulo-endothelial 
system.  These  agglutinating  antibodies  (IgM>IgG)  are  detectable  by  Microscopic 
Agglutination Test(MAT).
After  4-7 days,  the organisms persist  in  the aqueous humor  of  the eye,  the  renal 
tubules and are excreted in the urine. The Leptospiruria persists for 1-4 weeks in man.21
CLINICAL MANIFESTATIONS
Incubation period: Usually 7-12 days (range from 2-20 days).70
CLINICAL TYPES 
The clinical spectrum of leptospirosis is very wide, with mild anicteric presentation at 
one end to severe leptospirosis with severe jaundice and multiple organ involvement on the 
other.29
On the basis of these clinical features, two types of leptospirosis are described. 
Anicteric leptospirosis 
• It is the milder form of the disease. 
• Patients have fever, myalgia but do not have jaundice. 
• Almost 90% of patients have this type of illness. 
Icteric leptospirosis 
• It is the severe form of the disease. 
• It is characterized by jaundice and is usually associated with
   involvement of other organs. 
• About 5-10% of patients have these type of manifestations.66
The clinical presentation of leptospirosis is biphasic and have two defined stages an 
initial Septicemic stage that is followed by an Immune stage. These stages are  distinct in 
anicteric leptospirosis but not in icteric leptospirosis.91
ANICTERIC LEPTOSPIROSIS 
1) SEPTICEMIC STAGE
        This stage of the disease is abrupt in onset.17  The patients present with : 
• Fever -Patients have remittent fever with chills. It may be moderate to severe. 
•  Myalgia-It is a very characteristic finding in leptospirosis. Calf, abdominal & lumbosacral 
muscles are very painful  & severely tender. This symptom is very useful  in differentiating 
leptospirosis from other diseases causing fever. 
There is  associated increase in serum Creatinine Phosphokinase (C.P.K.)  which helps in 
differentiating leptospirosis from other illnesses.66 
•  Conjunctival  Suffusion-There is reddish colouration of  conjunctiva. Very useful  sign in 
leptospirosis. Usually bilateral, most marked on palpebral conjunctiva, it may be associated 
with unilateral or bilateral conjunctival haemorrhage. 
• Headache -Usually intense, sometimes throbbing, commonly in frontal region. It is often not 
relieved by analgesics. 
•  Renal manifestations -Some form of renal  involvement is  invariable in  leptospirosis.  It 
usually occurs as asymptomatic urinary abnormality in the form of mild proteinuria with few 
casts & cells in the urine. Severe renal involvement in the form of acute renal failure, (which 
occurs in icteric leptospirosis) is rare. 
• Pulmonary manifestations -Manifested in most cases through cough & chest pain and in 
few cases by haemoptysis. Severe involvement leading to respiratory failure does not occur in 
anicteric leptospirosis. 
• Hemorrhage- Hemorrhagic tendencies are also present in some cases. 
All the clinical features either decrease or disappear within two to three days and then they 
reappear.29
2) IMMUNE STAGE 
         The onset of immune stage coincides with the appearance of IgM antibodies. Aseptic 
meningitis is the hallmark of the immune stage.6   The CSF cell count is <500/mm3 in most 
cases. Polymorphonuclear cells may predominate early in the illness, but mononuclear cells 
predominate later. The  CSF protein levels ranges from <40mg/dl (normal) to 300 mg/dl and 
the  CSF  glucose  concentration  is  generally  normal.  Uveitis,  iritis,  iridocyclitis and 
chorioretinitis may also appear during the immune stage.91
• Differential diagnosis-The patients of anicteric leptospirosis are likely to be misdiagnosed 
as malaria, dengue hemorrhagic fever, viral hepatitis etc.
In endemic area all cases of fever with myalgia and conjunctival suffusion should be 
considered as suspected cases of leptospirosis. 
ICTERIC LEPTOSPIROSIS: -( WEIL’S SYNDROME ) 
This is the more severe form of leptospirosis. As the name suggests all patients have 
jaundice. Patients present with: - 
• Fever 
• Myalgia 
• Headache 
• Conjuctival suffusion 
• Oliguria/Anuria and/or proteinuria 
• Nausea, vomiting 
• Abdominal pain 
In addition, they have features of organ involvement. An individual patient may have 
features of one or more organ involvement. The more severe form of disease with severe liver 
and  kidney  involvement  is  known  as  Weil’s  syndrome.  Salient  features  of  these  organ 
involvements are described below. 29
Hepatic 
Jaundice is the most important clinical feature. It may be mild to severe. It starts after 4 
to  7  days  of  illness.  Hepatic  encephalopathy  or  death  due  to  hepatic  failure  is  rare. 
Hepatomegaly  &  tenderness  in  right  hypochondrium  are  usually  detected.  Laboratory 
investigations show raised level of serum bilirubin (direct) and alkaline phosphatase. SGOT & 
SGPT are either normal or mildly elevated. This helps to differentiate leptospirosis from viral 
hepatitis where SGPT is markedly elevated and also from alcoholic hepatitis where SGOT is 
markedly  elevated.  High  level  of  Creatinine  Phosphokinase  (CPK)  is  suggestive  of 
leptospirosis. It is normal in viral hepatitis and alcoholic hepatitis. 29
Renal 
Renal  involvement  is  almost  invariably  present  in  leptospirosis.  In  severe  cases 
patients have acute renal failure and present with: 
• Decreased urine output (oliguria or even anuria) 
• Oedema may be present on face and feet. 
•  Features  of  uremia  like  breathlessness,  convulsion,  delirium and  altered  level  of 
consciousness may be present in very severe cases.
The renal  dysfunction worsens during the first  week to  the end of 2nd week, after 
which it starts improving and complete recovery occurs by the end of the 4th week. There is 
usually no residual renal dysfunction.29 
Pulmonary involvement 
High mortality due to pulmonary involvement is becoming a feature in Leptospirosis. 
There are wide variations in pulmonary presentation. It is the commonest cause of death due 
to leptospirosis. 
Symptoms: In mild cases patient will show only cough, chest pain and blood tinged sputum. In 
severe cases patients  have cough,  haemoptysis,  rapidly increasing breathlessness which 
may  lead  to  respiratory  failure  and  death.  Leptospirosis  presenting  as  adult  respiratory 
distress syndrome has been described.18,58   On examination, these patients have increased 
respiratory rate with basal creptations, which rapidly spread upwards to middle and upper 
lobes. X-ray shows basal and mid zone opacity in severe cases. It may be normal in mild 
cases. The under lying pathology is intra-alveolar haemorrhage. 
More  than  ninety  percent  (90%)  of  deaths  in  cases  of  leptospirosis  occur  due  to 
pulmonary alveolar haemorrhage.29 
Cardiovascular system involvement 
Patients can have any one or more of the following features: 
1) Haemorrhage 
They  occur  because  of  1)  Thrombocytopenia,  2)  Disseminated  Intra-vascular 
Coagulation (DIC), 3) Secondary to liver involvement leading to coagulation factor deficiency. 
Patients may have spontaneous superficial bleeding i.e. petechial, purpura, epistaxis or GIT 
bleeding. In severe cases ecchymosis or intra-cranial haemorrhage can occur.29 
2) Hypotension Shock 
Patient will  have hypotension,  cold clammy extremities,  tachycardia,  thready pulse. 
JVP is either normal or decreased. Echocardiography reveals normal systolic function of left 
ventricle hence hypotension is due to either dehydration or peripheral vasodilatation. 
3) Arrhythmias
Patient presents with palpitation and syncope & irregular pulse. Common arrhythmias 
seen are supraventricular tachyarrythmias and various degrees of A.V. blocks. Ventricular 
tachyarrhythmias  are  infrequent.  ST  Segment  depression  and  T  wave  inversion  may be 
present in some patients.29
SUMMARY OF ORGANS AFFECTED IN ICTERIC LEPTOSPIROSIS:
Organ Clinical features Investigations reveal
Kidney Decrease in urine output,
Features of uremia
Increase in Serum Creatinine,
Increase in Blood Urea
Liver Jaundice, hepatomegaly Increase in Serum Bitirubin with 
Normal or midly elevated SGPT and 
SGOT and increased CPK
Lungs Cough, haemoptysis, dyspnoea 
with increase in respiration rate 
and basal creps
X  ray  chest  shows  lower  and  mid 
zone opacities
Heart Hypotension, Irregular pulse ECG reveals the type of arrhythmia
Blood Bleeding tendencies Decrease in platelet count
Brain Altered consiousness with
Neck rigidity
CSF  shoes  increase  in  cells, 
increase In protein, normal sugar
                                                               (Guidelines WHO 2006) 
LABORATORY DIAGNOSIS OF LEPTOSPIROSIS
The diverse clinical presentations of this disease make it essential for the laboratory to 
play a role in diagnosis. Microbiological diagnosis of leptospirosis aims at demonstrating the 
leptospires,  by  culturing  them or  by  demonstrating  an  appreciable  antibody response  to 
them.7 
DIRECT EVIDENCE(ANTIGEN DETECTION TESTS)
1. Demonstration of leptospires or their products:
Microscopy
• Dark-field microscopy 
• Phase contrast microscopy
Staining
• Silver staining 
• Immunofluorescence 
• Immunoperoxidase
 DNA hybridisation
 Polymerase chain reaction
 Random Amplified Polymorphic DNA Fingerprinting (RAPD) 
 2. Isolation of leptospires 
      Blood
      Urine
      CSF
      Body fluids and tissues
 3. Animal Inoculation
INDIRECT EVIDENCE
1. Detection of antibodies to leptospira
1) Genus specific tests
• Macroscopic agglutination test (MSAT) 
• Indirect fluorescent antibody test (IFAT) 
• Indirect haemagglutination test (IHA) 
• Counter immuno electrophoresis (CIEP) 
• Complement fixation test (CFT)
        Newer techniques
• Enzyme Linked Immuno Sorbent Assay (ELISA)
• Microcapsule agglutination test (MCAT) 
• Lepto-Dipstick
• Lepto lateral flow test
• Lepto DRI Dot
2) Serogroup/serovar specific tests
• Microscopic agglutination test (MAT) 
Collection of sample
Leptospires may be present in the blood and CSF in the first 7-10 days of illness and in 
the urine from the 10-14 day of illness to 30 day of illness. Aggulinating antibodies appear in 
the blood towards the end of the first week reaches the peak in the third or fourth week of 
illness and then gradually decline with low levels persisting for an indefinite period.
I.  Demonstration of Leptospires or their products.
Dark-Field Microscopy
The  typical  motility  of  the  leptospires  in  the  clinical  sample  (blood,  CSF,  urine  or 
peritoneal  fluid)  observed  with  dark-field  microscopes,  when  correlated  with  clinical 
parameters, may aid in early diagnosis. It is a simple method, but it may not be positive if 
there are few bacteria in the sample. Double centrifugation of the sample at low speed to 
separate the cellular elements, and then at high speed, is needed to help concentrate the 
leptospires. Artefacts like lysed RBCs, fibrils, etc. may however, be mistaken for leptospires. 
So it is not recommended as the only diagnostic procedure to be used .7
Phase contrast microscopy is useful for visualizing leptospires in the laboratory, but, 
because of its technical limitations in thick suspensions and its optical characteristics, it has 
no practical purpose whenever dark-field microscopy is available .19
Staining Methods
Silver deposition techniques: 
Leptospires  in  smears  of  tissues  or  fluids  on  slides  can  be  stained  using  silver 
deposition methods. The variously described procedures are modifications of Warthin Starry's 
method  for  staining.  The  stain  is  based  on  chemically  reducing  surface  properties  of 
leptospires and other  spirochaetes.  Well-stained preparations show black spirochaetes  in 
pale  yellow or  brown tissue elements.  This method has the same limitation as dark-field 
procedures, as it  is difficult  to detect small  numbers of organisms in tissue sections, and 
artefacts may be mistaken for leptospires .19
Immunofluorescence 
Immunofluorescence  staining  of  leptospires  is  often  preferable  to  silver  staining 
because it  is  easier to see leptospires, especially in small  numbers, and the serovars or 
serogroups can be determined presumptively. When a combination of antisera labelled with 
different  fluorochromes  is  used,  more  than  one  serological  type  of  leptospires  can  be 
identified  in  the  same preparation.  One disadvantage is  the  need for  special  fluorescent 
microscopy equipment; another is that specially prepared labelled antisera are required. A 
double layer or sandwich method is used with primary specific anti leptospiral antisera and a 
secondary universal fluorochrome labelled anti rabbit globulin serum.70
DNA hybridisation
        Leptospira specific DNA sequences can be hybridised to leptospiral DNA extracted from 
clinical specimens. The reaction can be visualised with the help of an avidine biotinylated 
peroxidase complex plus a colour reagent. This technique is not very sensitive.
Polymerase chain reaction (PCR)
            PCR involves in vitro enzymatic amplification of a target DNA sequence through a 
series of polymerisations carried out by a thermostable DNA polymerase, primed with a pair 
of the short DNA fragments, which bind specifically to the sequence of interest. Amplified 
DNA fragments produced by this technique can be easily visualized on ethidium-bromide-
stained agarose gels with a UV transilluminator.67
Random amplified polymeric DNA (RAPD) finger printing
This  is  another  molecular  typing  method  based  on  PCR  amplification  and  finger 
printing, using arbitrary oligonucleotide primers, which produces reliable and easily obtainable 
typing schemes67.
2) Culture of leptospira
The infecting strains can often be isolated in culture, provided that suitable material is 
obtained before antibiotics have been administered. Early in the course of illness – during the 
leptospiraemic phase – the inoculum of preference is blood or cerebrospinal fluid; later during 
the phase of leptospiruria – it is urine. It is particularly valuable in man, as the serological 
response can be slow and may be absent  altogether if  antibiotics are given early.  Since 
serology is usually serogroup specific, isolation is essential to identify the infecting serotype. 
Such  information  is  essential  for  epidemiological  purposes,  for  the  selection  of  relevant 
leptospires  for  use  in  diagnostic  tests,  vaccine  preparation  and  for  the  assessment  of 
antibiotic sensitivity.70
3) Animal inoculation
Laboratory animals are useful for isolating the organisms from contaminated materials 
and for maintaining recent isolates. They are also sometimes essential for decontaminating 
cultures,  and with  the help  of  passive  protection,  they may be used to  recover  a  single 
serotype  from  a  mixed  culture.  Young  animals,  preferably  weanlings,  should  be  used 
because older animals may resist the infection. Stocks must be free from endemic leptospiral 
infection; guinea pigs, hamsters, gerbils, young rabbits, swiss white mice, albino American 
deer  mice  and  1  to  3  day-old  chicks  may  be  used.  The  material  should  be  inoculated 
intraperitoneally  through  one of  the  lower  quadrants  of  the  abdominal  wall.  The animals 
should be examined twice daily, and a drop of peritoneal fluid can be examined with dark-field 
microscopy for active leptospires from the 3rd to the 7th day.75 
II. Serological Methods(Detection of antibodies to leptospira)
Serological tests can be a guide to the infecting serum and this information is useful for 
prognosis and epidemiology. Serological tests do not react until a few days after infection, but 
reactions persists for months or years. Persistent antibodies allow retrospective diagnosis,21 
but seroconversion or a 4-fold or greater rise in titre in paired serum samples in the presence 
of  a  compatible  clinical  illness  is  an  important  criterium  for  the  definitive  diagnosis  of 
leptospirosis.  The wide  range of  tests  that  are  available  are  broadly  divided into  genus-
specific and serogroup/serotype-specific tests.
1) Genus Specific Tests 
The antigen for these tests is prepared from the non-pathogenic L. biflexa Patoc – 1 strain.
1. MACROSCOPIC SLIDE AGGLUTINATION TEST (MSAT) 
              A rapid macroscopic slide agglutination test can be used to screen serum samples.  
These tests are carried out with a dense suspension of leptospires, which agglutinate into 
clumps visible to the naked eye. The best method is Galton's macroscopic slide agglutination 
test, in which 12 antigens were originally proposed, and later supplementary antigens were 
suggested.25   MSAT is found to be a simple, rapid, and sensitive diagnostic test for active 
leptospirosis; the sensitivity of the test can be improved by the addition of locally prevalent 
serovars.83  This test is slightly less specific than MAT, but it gives a positive reaction earlier in 
disease.
2. INDIRECT IMMUNOFLUORESCENCE TEST
In  1966,  Patoc  strain  1  was  used  in  an  indirect  immunofluorescence  test. 
Immunofluorescence has not  been used widely for  primary diagnostic tests.  It  is  used to 
detect leptospirosis in tissues.20  This is a fast and reliable test, where facilities are available. 
It has a sensitivity of 91.4%.7
3.INDIRECT HAEMAGGLUTINATION TEST (IHA)
        This  is  a  genus  specific  test  where  the  broadly  reactive  antigen  is  coated  on 
erythrocytes. This test can be done in microtitre plates or tubes.
4. COUNTER IMMUNO ELECTROPHORESIS(CIEP)
        The patient serum and  antigen are allowed to move under the influence of electric 
current through a gel. Presence of antibodies can be detected by a visible precipitate.
5. COMPLEMENT FIXATION TEST(CFT)
          It is a complicated technique and is not used in diagnostic laboratories.
6.ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)
         This is for the detection of IgM antibodies that has been shown to be more sensitive 
than MAT when the sample was taken early in the acute phase of the illness. IgM antibodies 
have been detected by ELISA in CSF from patients with icteric Leptospirosis. ELISA methods 
have been applied with a number of modifications. 
An IgM specific dot ELISA was developed in which polyvalent leptospiral antigen was 
dotted on to nitrocellulose filter  discs in microfilter  tray wells,  allowing the use of smaller 
volumes of reagents. Further modifications of this approach have been used to detect IgG 
and IgA in addition to IgM tests. These tests have employed an immunodominant antigen and 
a polyster fabric resin support in place of nitrocellulose. A Commercial IgM-dot ELISA dipstick 
has been shown to be as sensitive as microtitre plate IgM-ELISA.3
7. MICROCAPSULE AGGLUTINATION TEST (MCAT) 
     This  test  was  developed  for  serodiagnosis  of  Leptospirosis,  based  on  the  passive 
agglutination  of  synthetic  polymer  carriers,  sensitized  with  mixed  antigens  of  sonicated 
leptospires, by leptospiral antibody.. The MCAT gave positive results earlier in the course of 
the disease but may not detect antibodies in sera collected more than 1 to 2 months after the 
onset of disease.75               
8. LEPTO DIPSTICK 
This dipstick assay is for the detection of leptospira-specific IgM antibodies in human 
sera Heat stable antigen prepared from Leptospira biflexa and coated onto the lower band 
and internal control is set up in the upper band; detection agent is also incorporated. The 
strength of staining is important in interpretation of test results. This test is simple to perform 
and easy to read but expensive.
9. LEPTO LATERAL FLOW TECHNIQUE
 It is a rapid colloidal gold immunoassay technique in which the antibody in the serum 
which  is  added  on  to  the  vent  permeates  along  nitrocellulose  membrane  picks  up  the 
conjugate and reacts with antigen impregnated on the test band and produces a colour which 
is compared with a given positive control band.
10.  LEPTO DRI - DOT ASSAY
           This assay consists  of  coloured latex particles activated with broadly reactive 
leptospiral  antibody that  is  dried  onto  an agglutination card.  This  assay is  based on the 
binding of leptospira specific antibody present in the serum sample to the antigen causing a 
fine granular agglutination that tends to settle at the edge of the droplet.80
2) Serovar/Serogroup specific Tests
1. MICROSCOPIC AGGLUTINATION TEST (MAT) 
The MAT is slow, tedious, potentially biohazardous, painstaking and subjective; but it 
is a very sensitive and reliable assay.  MAT is carried out with suspensions of live cultures or 
of  cultures  killed  by  the  addition  of  formaldehyde.  The  clumps  of  agglutinated  living 
leptospires  differ  in  appearance  from  clumps  of  killed  cultures.  Living  leptospires  are 
agglutinated into highly refractile spheroids of various sizes, some of which may be joined to 
produce  elongated  masses  of  confluent  spheroids.  By  contrast,  the  agglutinated  killed 
leptospires  form  looser  masses  with  an  irregular  often  angular,  outline;  these  appear 
flattened, resembling small  piles of threads, or snowflakes, or pieces of cotton wool. The 
degree of agglutination ranges from 100%, when no free leptospires can be seen between 
the clumps, through lesser degrees, as the serum is more diluted,  to nil,  as seen in the 
negative control suspension of leptospires in diluent. The degree of agglutination can only be 
assessed  in  terms  of  the  proportion  of  free  leptospires.  The  accepted  endpoint  of  an 
agglutination reaction is the final dilution of serum at which 50% or more of the leptospires 
are aggluatinated.89
       Interpretation of diagnostic MAT: In a non-endemic area any level of antibodies, however 
low, may signify leptospirosis in the 1st week of a clinically compatible illness. The titer will rise 
in  a  second specimen taken after  3  to  7  days.  If  the  titer  remains  below 100,  even on 
repeated testing, it may be assumed that it was due to previous leptospirosis, and not to 
current illness. A titre of  400 to 800 or more, or  a 4-fold rise in titer  between 2 tests,  is 
diagnostic when combined with a clinical illness compatible with leptospirosis. In endemic 
areas, the diagnosis will be confirmed if the titre rises on retesting, but will be negated if it is 
unchanged, assuming that the infecting serovar was included among the antigens for the 
MAT.22
LEPTOSPIROSIS WITH CONCOMITANT ILLNESSES
Leptospirosis can occur with other infections as dual infection in the same patient.3 
Dengue                                                                                                  
Concurrent  epidemics  of  leptospirosis  and  dengue  fever  because  of  their 
epidemiological similiarities have been reported.24,38,44 Kaur and  John reported dual infection 
with leptospira and dengue fever virus39. In the year 2002, in Mumbai concurrent outbreaks of 
leptospirosis and dengue occurred.86 In a study at Brazil, Ko Al Galvao Reis (1994) reported 
misdiagnosis of leptospirosis as dengue in the outpatient clinic.42 During the second half of 
1995, an epidemic of degue type I infection occurred. In that period, leptospirosis mortality 
was twice the average, suggesting that some cases of leptospirosis were being misdiagnosed 
and treated inappropriately.47
HepatitisB                                                                                                                 
Weil’s syndrome characterised by jaundice, renal failure and bleeding manifestations 
is  the  most  severe  form  of  leptospirosis.  Weil’s  syndrome  and  concominant  Hepatitis  B 
infection infection have been reported by Kaushik and Colleagues.* Weil’s disease is likely to 
be misdiagnosed or overlooked in patients with chronic Hepatitis B virus infection due to 
potentially  overlapping clinical  features.45  A high  index of  suspicion for  Weil’s  syndrome 
resulted  in  the  prompt  use  of  high  dose  of  Penicillin  and  the  patient  recovered  from 
leptospirosis  despite  the  severe  systemic  manifestations  of  leptospirosis  and  combined 
hepatic involvement of these two illnesses.40 
               Dual infection with Hanta virus, Hepatitis E virus, Malaria parasites, Herpes Simplex 
virus, Scrub typhus and coinfection with three different pathogens has also been reported but 
rare.4,43,87 
TREATMENT 
Penicillin,  Streptomycin,  Tetracycline,  Erythromycin  and  cephalosporins  are   the 
antimicrobials capable of killing leptospires. Early institution of antimicrobial treatment may 
prevent complications like renal failure. Parenteral aqueous benzyl penicillin in a dosage of 1 
mega unit  6 hourly for  a period of  1 week is  recommended.   For  patients  with  penicillin 
hypersensitivity, tetracycline at a dosage of 2g daily is recommended provided renal function 
is normal. Doxycycline (200 mg daily) and third generation cephalosporin like cefataxime or 
ceftriaxone given intravenously are also found to be highly effective.
PREVENTION
Prevention  consists  of  avoiding  direct  or  indirect  exposure  of  humans  to  infected 
animal urine and tissues. Occupational hygiene, protective clothing and safe work practices 
are  important  in  preventing  the  disease  in  working  population.  Vaccines  are  effective  in 
preventing the disease in animals. The outer membrane vaccine is more effective than the 
whole cell  and protoplasmic cylinder vaccine. Its use on man is impracticable due to the 
presence of many serovars. However vaccination against a specific serovar prevalent in the 
area has been shown to be effective.  Chemoprophylaxis with  Doxycycline 200mg weekly 
prevents infection but is recommended only for short term use in high risk individuals.21
               
Aims of the Study
AIMS OF THE STUDY
 To study and correlate the haematological, bio-chemical and radiological parameters in 
the diagnosis of leptospirosis.
 To identify the predominant serovar in leptospirosis
 To study the concomitant infection of leptospirosis with Dengue and Hepatitis B 
Materials & Methods
MATERIALS AND METHODS
STUDY PERIOD
March 2007- February 2008  
   
PLACE WHERE STUDY WAS CONDUCTED
Leptospirosis  Research  Cell  (LRC),  Institute  of  Microbiology,  Madras  Medical 
College(MMC), Chennai-3.
STUDY POPULATION
           This cross sectional study included 378 patients who attended Government General 
Hospital, Chennai with fever of 5 days  and more duration and of the age group 11 years and 
above. Only patients with features suggestive of leptospirosis were included in this study. 
Patients with fever associated with malignancies, autoimmune diseases were excluded from 
this study.
ETHICAL CONSIDERATION
           Written consent to participate in the study was obtained from the patients or their 
guardians after providing the full explanation of the study to them. This study was reviewed 
and  approved  by  Institutional  Ethical  Committee,  Madras  Medical  College  and  General 
Hospital, Chennai – 3. All datas were handled confidentially and anonymously.
INSTITUTIONAL ETHICAL COMMITTEE APPROVAL NUMBER 
K.Dis.No.16328 P & D3/Ethics/Dean/GGH/08.
STATISTICAL ANALYSIS
           Demographic  and  clinical  variables  were  given  in  frequencies  with  their 
percentages.Incidence  were  given  in  proportion  with  95%  confidence  interval.  Statistical 
difference were found using one sample chi-square test. p<0.05 were considered statistically 
significant.
MATERIALS
• 378  blood  samples  were  collected  from  patients  with  clinical  symptoms 
suggestive of leptospirosis during this study period.
• From all  these patients   2ml  of  blood was collected by venepuncture with 
aseptic  precautions  and  the  serum  was  subjected  to  serological  test  for 
leptospirosis – MSAT.
• 156 sample out of this were positive for the serological test MSAT.
• Detailed clinical history was obtained from all positive cases of leptospirosis.
• Biochemical profile, haematological parameters and radiological parameters of 
the leptospirosis positive patients  were studied.
• 10  ml  of  blood  was  collected  from  these  patients,  serum  separated  and 
investigated for 
1. Dengue IgM, antibody capture ELISA, 
2. Rapid test - Dengue Duo cassette.
3. HBs Ag capture ELISA.
4. Rapid test – One step Cassette Style HBsAg Test
                          ALGORITHM OF TESTING PROCEDURE
TOTAL BLOOD SAMPLE
378
METHODS
Leptospiral  serovars  autumnalis,  australis,  icterohaemorrhagiae,  Louisiana,  
grippotyphosa, hebdomadis canicola semaranga were used for MSAT and MAT. The above 
standard research strains were obtained from KIT and Royal Tropical Institute, Netherlands 
and subcultured periodically in LRC, Institute of Microbiology, MMC, Chennai-3.
MEDIUM
                          EMJH (Ellinughausen – Mccullough – Johnson – Harris)    medium was used 
for subculturing the organism for maintenance and antigen preparation.
MACROSCOPIC SLIDE AGGLUTINATION TEST (MSAT)
(Mazzonelli et al 1974)52
• Different serovars of leptospira were grown in EMJH liquid medium for 7 days at 
30ºC in a shaking incubator.
MSAT
MAT 
1. HBsAg  Capture Elisa 
2. One step Cassette 
Style HBsAg test           
1.IgM  dengue Elisa
2.Rapid test dengue 
Duo cassette
• After checking for growth and purity the leptospires were killed in formalin,(0.5ml 
of formaldehyde in 100ml culture).
• After 30mts the killed leptospira culture was kept in boiling water bath for 30 
mts.
• The culture was rotated at every 15 mts
•  After  cooling to room temperature, the culture was centrifuged for 30mts at 
10,000 rpm.
• .The supernatant was used as antigen. A pooled suspension of locally prevalent 
serovars  namely  icterohaemorrhagiae,  autumnalis,  australis,  louisiana, 
grippotyphosa, hebdomadis,canicola  and semaranga  were used as antigens in 
MSAT.
PREPARATION OF PHOSPHATE BUFFER SALINE (PBS)(Ph 7.2) 
NaCl 8gm/litre
K2HPO4 1.12gm/litre
KH2PO4 0.34gm/litre
Distilled water 1 litre
PROCEDURE
• 8µl of PBS was added to all the depressions of the slide
• Then 11µl of the prepared antigen was added to all the depressions of the slide
• Negative serum added with antigen and PBS was used as negative control
• Positive serum added with antigen and PBS was used as positive control
• The last depression containing saline and antigen was used as antigen control
• 4ml of patients serum was added to the depressions in the slide
• The slide was placed in a rotator (180rpm) for 8 mts
• The slide was viewed macroscopically for  the presence of  any agglutination 
clumps and was confirmed in DFM
• The results of MSAT were read as follows:  
 1. Clumps of Agglutination with complete clearing of leptospiral antigen 4+
2. Obvious Agglutination with partial clearing of antigen suspension 3+
3. 50% Agglutination 2+
4. 25% Agglutination 1+
       No agglutination and uniformity of serum antigen mixture-Negative.
INTERPRETATION OF RESULTS 
        An agglutination of  ≥2  is considered as positive for leptospirosis.
MICROSCOPIC AGGLUTINATION TEST
(Sulzer and Jones 1976) 82
The  MAT  was  performed  with  eight  (8)  live  cultures  using  standard  microtitre 
methodology.
S.NO ANTIGEN PANEL
1. L .icterohaemorrhagiae
2. L .australis
3. L .autumnalis
4. L .hebdomadis
5. L .grippotyphosa
6. L .louisiana
7. L .canicola
8. L .semaranga
 
The sera were initially screened at dilution of 1:20 and those that were positive were 
titrated further upto the end point. The highest dilution of  serum that agglutinated 50% of 
leptospires under  dark field  microscopy were presumed to  represent  the titre  of  antibody 
specific for the particular serogroup used. When two or more serogroups react at the same 
(highest) titre, the result was recorded as mixed equal. Controls were put up for each one of 
the battery of the antigens used in the test.
PROCEDURE
The sera diluted to 1:10 in separate test tubes.
• 25µl of PBS was added to all the wells in the microtitre plate
• The sera was diluted by doubling dilution as 1:20, 1:40 upt0 1:320
• Last well serves as a control containing only PBS and antigen
• 25µl of antigen was added to each well in the row(Each row of the microtitre 
plate was used for serovar from the panel)
• The serum antigen mixture then mixed by gentle agitation and it was kept at 
room temperature for 2 hrs
• One  drop  from  each  well  was  examined  from  lower  dilution  onwards  after 
examining the antigen control
• By dark field microscopy, agglutination masses and free organisms were looked 
for.
INTERPRETATION OF RESULTS
The highest dilution of serum antigen mixture, which showed 50% agglutination was 
taken as the end point titre of the serum for that particular antigen.
CRITERIA FOR DIAGNOSIS
An initial titre > 1.80 or a four fold rise in titre of MAT was considered as positive.
DENGUE IgM CAPTURE ELISA: (PANBIO)
Detection of IgM antibodies to dengue virus by ELISA is a valuable procedure. The IgM 
antibodies appear as early as 3 to 5 days after the onset of fever and generally persist for 30 
to 90 days.
Principle:   (Appendix iii).
PROCEDURE
1. Dilute the antigen 1/250 using the antigen diluent.
2. The required amount of diluted antigen is mixed with an equal volume of MAb tracer 
in a plastic vial.
3. The antigen-MAb tracer solution was gently mixed and left at room temperature.
4. Within 10 minutes after  mixing the MAb tracer  and diluted antigen,  pipette  100µl 
diluted patient samples into their respective microwells of the assay plate leaving A1 
to E1 wells.
5. In A1 positive control serum in B1 negative control serum and in C1 , D1 , E1 cut off 
calibrator serum were added.
6. Cover the plate and incubate for 1 hour at 37°C± 1°C.
7. Wash 6 times with diluted wash buffer.
8. Mix the antigen-MAb tracer  solution before transfer  pipette  100µl  of  antigen-MAb 
complexes from the antigen vial to the appropriate wells of the assay plate.
9. Cover the plate and incubate for 1 hr at 37°C.
10.  Wash 6 times with diluted wash buffer.
11.  Pipette 100µl of stop solution to all wells in the same sequence and timing as the 
TMB addition. Mix well. The blue colour will change to yellow.
12.  Within 30 minutes read the absorbance of each well at a wavelength of 450nm with 
a reference filter of 600 to 650 nm.
CALCULATIONS
Average absorbance of the triplicates of the cut off  calibrator = cut off value.
Sample absorbance           =       Index value
           ---------------------------
            cut off value
(OR)
Index value × 10 = Panbio units
 INTERPRETATION OF RESULTS
Index Panbio units Result
< 0.9 < 9 Negative
0.9 – 1.1 9 – 11 Equivocal
> 1.1 > 11 Positive
DENGUE DUO CASSETTE
       This is a rapid test done for the qualitative presumptive detection of IgM and IgG 
antibodies to dengue virus in human serum, plasma or whole blood. 
TEST PROCEDURE
• 10µl of serum was added to the sample well using a micropipette. 
• 2 drops of buffer was added to the square well at the base of the cassette.
The result were read exactly 15 minutes after adding the buffer to the cassette.
    Any trace of a pink line in the test area indicated a positive result.
INTERPRETATION OF RESULTS
1. Primary infection: Pink bands appeared in the IgM and control regions.
2. Secondary infection: Pink bands appeared in the IgM, IgG and control regions or on 
the IgG and control regions.
3. Negative result: Pink bands appeared in the control region. No bands in the IgM or IgG 
regions.
4. Invalid test:  No band appeared in the control region. 
 HBsAg ELISA TEST KIT – (HEPALISA)
PRINCIPLE  
This is a solid phase enzyme linked immuno sorbent assay (ELISA) based on 
the ‘Direct Sandwich” principle.
PROCEDURE   
• Leave A-1 well as blank.
• Add 50 µl Negative control in each well No. B-1 and C-1 respectively.
• Add 50 µl Positive control in D-1, E-1 and F-1 wells.
• Add 50 µl of sample in each well starting from G-1.
• Add 50 µl of working Enzyme conjugate to each well except A-1. Gently shake 
the plate for 2 to 3 seconds to mix the sample and conjugate.
• Cover the plate and incubate in an incubator at 37°C ± 1°C for 60 minutes.
• Dilute the wash buffer concentrate with distilled water to 1:25 dilution.
• At the end of incubation period, take out the plate from incubator and wash with 
working wash buffer.
• Tap dry the wells after washing and add 100 µl od working substrate solution in 
all the wells including A-1.
• Cover  the  plate  with  an  aluminium  foil  and  incubate  at  room  temperature 
(20-25°C) for 30 minutes in dark.
• Stop the reaction by adding 50 µl of stop solution to each well, mix gently.
• Read the absorbance of the wells at 450 nm in an Elisa Reader after blanking 
A-1 well. (Use of a reference filter of 630 nm is preferred).
CUT OFF CALCULATION
Cut off value = NC mean + 0.1
where NC mean is mean absorbance(O.D) of Negative Control.
INTERPRETATION OF RESULTS
The absorbance of the unknown sample is compared with the calculated cut off 
value.
• Test specimens with absorbance (O.D) value less than cut off value are non-
reactive and may be considered as negative for HBsAg.
• Test specimens with absorbance (O.D) value greater than or equal to cut off 
value are reactive for HBsAg.
ONE STEP CASSETTE STYLE HBsAg TEST
This is a rapid, direct binding test for the visual detection hepatitisB surface antigen 
(HBsAg) in serum  based on the principle of sandwich immunoassay.
TEST PROCEDURE:
• About 3 – 4 drops of sample was added onto the sample well of the cassette.
• Wait for 10 – 20 minutes and read results.
INTERPRETATION OF RESULTS
1. Negative result: Only one colored band appears on the control (C) region. No 
apparent band on the test (T) region.
2. Positive result: In addition to a pink colored control (C) band, a distinct pink colored 
band will appear in the test (T) region. 
3.  Invalid Test:  A total absence of color in both regions or no colored line appears in the 
control (C) region.
Results               
RESULTS
  Total No of samples taken :   378
  Total No of MSAT positive samples :   156
  Total No of samples included in the study :   156
TABLE 1
MACROSCOPIC SLIDE AGGLUTINATION TEST
Total 
samples
Procedure No. of positive 
cases
Percentage
378 MSAT 156 41.26
     41.26% of patients were positive by MSAT.                                                              95% 
Confidence Interval is 36% - 46%.
 TABLE 2     
AGE DISTRIBUTION n=156
Age No. of Cases Percentage
11-20 21 13.46
21-30 37 23.71
31-40 31 19.87
41-50 30 19.23
51-60 23 14.74
>60 14   8.97
The incidence was relatively higher in 21-30 age groups
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TABLE 3
SEX DISTRIBUTION  n=156  
  
Gender No. of cases Percentage
Males 80 51.28
Females 76 48.71
There was almost equal incidence of leptospirosis in males and females with very 
slight preponderance in males. One Sample Chi-square test x²=0.10,p=0.75.
TABLE 4
SEASONAL DISTRIBUTION OF INCIDENCE OF LEPTOSPIROSIS n=156
Month No. of cases Percentage
March ‘07 11 7.05
April   ’07 10 6.41
May   ’07 12 7.69
June ‘ 07 10 6.41
July   ’07 13 8.33
August ’07 14 8.97
September ’07 15 9.61
October ’07 13 8.33
November ’07 14 8.97
December ’07 15 9.61
January   ’08 15 9.61
February  ’08 14 8.97
       
Incidence of leptospirosis was seen throughout the year, although the number of cases 
increased after rainy season.
Sex Distribution in Leptospirosis
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TABLE 5
SYMPTOMS OF CASES PRESENTING WITH LEPTOSPIROSIS n=156
Fever was 
the 
predominant symptom followed by high coloured urine,
vomiting, headache.
Symptoms No. of cases Percentage
Fever 156 100
High coloured urine 98 62.82
Vomiting 75 48.07
Headache 63 40.38
Abdominal pain 54 34.61
Diarrhoea 53 33.97
Cough 53 33.97
Myalgia 50 32.05
Breathlessness 31 19.87
Pedaloedema 18 11.53
Conj. Suffusion 17 10.89
Joint pain 16 10.25
Dysuria 13 8.33
Hemoptysis 9 5.76
Giddiness 8 5.12
Oliguria 8 5.12
Restlessness 7 4.48
Haematuria 7 4.48
Altered sensorium 7 4.48
Skin rashes 5 3.20
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TABLE  6
SIGNS OF CASES PRESENTING WITH LEPTOSPIROSIS  n=156
Signs No. of cases Percentage
Jaundice 112 71.79
Hepatomegaly 51 32.69
Hypertension 49 31.41
Anemia 32 20.51
Splenomegaly 30 19.23
Hypotension 3   1.92
Polycythemia 1    0.64
Jaundice was found to be the predominant sign.
                                                               
TABLE  7
MICROSCOPIC AGGLUTINATION TEST IN LEPTOSPIROSIS
No. of samples 
screened No. of positive samples Percentage
156 143 91.66
143 samples(91.66%) were positive for MAT
95% Confidence Interval is 86.51% - 95.3%.
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TABLE 8
SEROVAR DISTRIBUTION IN LEPTOSPIROSIS POSITIVE CASES  n=143
Serovar Positive titres1/80 1/160 1/320 Total Percentage
L.icterohaemorrhagiae 14 51 6 71 49.65
L.australis 10 25 6 41 28.67
L.semaranga 3 11 5 19 13.28
L. grippotyphosa 6 3 - 9   6.29
L.canicola 1 2 - 3   1.92
L.louisiana - - - - -
L. autumnalis - - - - -
L. hebdomadis - - - - -
L. icterohaemorrhagiae was the predominant serovar
TABLE 9
SEROVAR DISTRIBUTION IN JAUNDICE CASES  N=112
Serovar No. of cases Percentage
L. icterohaemorrhagiae 75 66.96
L. australis 24 21.42
L. semaranga 11 9.82
L. grippotyphosa   2 1.78
L. canicola - -
L. louisiana - -
L. autumnalis - -
L. hebdomadis - -
L. icterrohaemorrhagiae was the predominant serovar in jaundiced patients
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TABLE 10
INVESTIGATIONS IN PATIENTS WITH LEPTOSPIROSIS N=156
Investigations No. of cases Percentage
Elevation of ESR 156 100
Abnormal LFT 112 71.79
Thrombocytopenia 79 50.64
Abnormal RFT  42 26.92
Abnormal LFT and RFT  34 21.79
ESR raised in all cases (100%), followed by abnormal LFT in 71.79% of patients
TABLE 11
TOTAL WBC COUNT IN LEPTOSPIROSIS n= 156
WBC count No. of cases Percentage
4,000-10,000 86 55.12
>10,000 44 28.20
<4,000 26 16.66
WBC count was normal in 55.12% of patients
TABLE   12
   DIFFERENTIAL COUNT IN LEPTOSPIROSIS n= 156
Differential count No. of cases Percentage
Polymorphs increased 104 66.66
Lymphocytes increased 17 10.89
Both normal 35           22.34
Polymorphs % was increased in 66.66% of patients
TABLE   13
ELEVATION OF ESR IN LEPTOSPIROSIS n= 156
Level raised No. of cases Percentage
20-50mm/hr 118 75.64
>50mm/hr 38 24.35
ESR was moderately increased in 75.64% of patients
TABLE   14
PLATELET COUNT IN LEPTOSPIROSIS n=156
Platelet Count 
cells/cmm No. of cases
Total 
cases Percentage
1,50,000 – 2,50,000 77 77 49.35
1,00,000 – 1,50,000 39
50,000 – 1,00,000 31
<50,000  9
79 50.64
Thrombocytopenia was seen in 50.64% 0f patients.
TABLE 15
RENAL FUNCTION TESTS IN LEPTOSPIROSIS n=156
Renal parameters Range No. of cases Total cases Percentage
Creatinine
mgm/dl
<1.5 114 114 73.07
   1.5 -2.0 26
  2.0 – 2.5 5
  2.5 – 3.0 1
     >3.0 10
42 26.92
Urea
mgm/dl
 20  - 40 114 114 73.07
 40 – 50 15
 50 - 100 16
   >100 11
42 26.92
Blood urea, Serum creatinine raised in 26.92 % of patients.
TABLE 16
ACUTE RENAL FAILURE IN LEPTOSPIROSIS n=156
Total cases 
Screened
No. of cases Percentage
156 2 1.28
2 patients(1.28%) went in for acute renal failure
TABLE 17
CORRELATION OF INCREASED RENAL PARAMETERS WITH PLATELET COUNT  n=42
Parameters Platelet count No. of cases Percentage
Increased Blood 
Urea and Serum 
Creatinine
< 1,50,000 38 90.47
1,50,000 – 
2,50,000
4 9.52
Renal parameters were found to be increased in more number of thrombocytopenic 
patients.
TABLE 18
SERUM BILIRUBIN (TOTAL) IN LEPTOSPIROSIS n=156
Serum Bilirubin
mgm/dl No. of cases Total cases Percentage
<1 44 44 28.20
1-5 76
5 - 10 15
>10 21
112 71.79
Total serum bilirubin raised in 71.79% and normal in 28.20%.
TABLE  19
SERUM GLUTAMIC OXALO ACETIC TRANSAMINASE (SGOT) IN 
LEPTOSPIROSIS N=156
SGOT
IU/L No. of cases Total cases Percentage
5-40 62 62 39.74
41 - 60 30
61 - 80 25
81 - 100 14
>100 25
94 60.25
SGOT was found to be normal in 39.74%, and raised in 60.25%.
TABLE 20
SERUM GLUTAMIC PYRUVIC TRANSAMINASE (SGPT) IN LEPTOSPIROSIS   n=156
SGPT
IU/L No. of cases Total cases Percentage
7-35 65 65 41.66
36 – 60 31
61 – 80 30
81 - 100 9
>100 21
91 58.33
SGPT was found to be normal in 41.66% and raised 58.33%. 
TABLE 21
SERUM ALKALINE PHOSPHATASE (SAP) IN LEPTOSPIROSIS n=156
SAP
IU/L
No. of cases Total cases Percentage
15 - 121 66 66 42.30
I21 -150 10
151- 180 7
>180 73
90 57.69
SAP was found to be raised in 57.69%.
  
TABLE 22
RADIOLOGY IN LEPTOSPIROSIS  n=156
 
Parameter Findings No. of cases Percentage
X ray chest
Bilateral Lower 
Lobe Opacity
4 2.56%
Pulmonary involvement was present only in 4 (2.56%) patients
TABLE 23
CONCOMITANT INFECTION OF LEPTOSPIROSIS WITH DENGUE, HEPATITIS B 
n=156
Dual infections No. of cases Percentage
Leptospirosis with dengue 4 2.56%
Leptospirosis with hepatitis B 1 0.64%
Out of 156 samples ,four (2.56%) were positive for dengue IgM antibodies and one for 
HBsAg.
Leptospirosis and its concomitant infections
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TABLE 24
CLINICAL SIGNS AND SYMPTOMS IN PATIENTS WITH DENGUE COINFECTION n=4
Signs and symptoms No. of cases Percentage
Fever 4 100
Myalgia 3 75.00
Hemorrhage 1 25.00
Hepatomegaly 1 25.00
Splenomegaly 1 25.00
Rash - -
Conj.suffusion - -
Abdominal pain - -
Jaundice - -
TABLE 25
LABORATORY PARAMETERS IN PATIENTS WITH DENGUE COINFECTION n=4 
Parameters No. of cases Percentage
Differential count
Polymorphs raised
2
50.00
Lymphocytes raised 2 50.00
PLATELET COUNT/cu.mm
>2.5 lakhs 1 25.00
1.0 -1.5 lakhs 2 50.00
<50,000 1 25.00
TABLE 26
CLINICAL SIGNS AND SYMPTOMS IN PATIENT WITH HEPATITIS B n=1
TABLE 27
LABORATORY PARAMETERS IN PATIENT WITH HEPATITIS B COINFECTION    n=1 
Parameters Values Interpretation
Total WBC count/cu.mm 8,750 Normal
Differential 
count
Polymorphs 85% Increased
Lymphocytes             12% Decreased
ESR mm/hr 29 Increased
Blood urea mgms/dl 56 Increased
Serum creatinine mgms/dl 3.4 Increased
Serum bilirubin-total mgms/dl 21.8 Increased
Serum bilirubin-direct mgms/dl 15.2 Increased
Serum bilirubin- indirect mgms/dl 6.6 Increased
SGOT   IU/L 172 Increased
SGPT  IU/L 78 Increased
SAP  IU/L 190 Increased
Signs and symptoms Duration
Fever 8 days
Headache 8 days
Myalgia 8 days
Vomiting  6 days
High coloured urine  4 days
         Discussion
DISCUSSION
Leptospirosis  is considered as an emerging disease and this has led to an increased 
interest and demand for  information, notably in developing countries. This infection is a public 
health threat due to its morbidity and mortality. The detailed knowledge of its clinical features 
and  other  laboratory  parameters  is  necessary  for  early  clinical  diagnosis  which  is  then 
confirmed by serological tests.
The cross sectional  study was conducted over a period of  one year (March 2007-
February  2008).  Out  of   378  samples  which  were  with  clinical  features  suggestive  of 
leptospirosis, MSAT was positive in 156 samples (41.26%)(Table 1).  MSAT is a rapid test 
used to  identify if  the person is  infected or  not.  It  detects  the IgM antibodies.  Sensitivity 
increases after a week’s time. Galton et al  found that patoc strain with killed Ag used for 
MSAT was more sensitive in the second week of illness.26   The usefulness of MSAT as a 
screening test has been evaluated by Sumathi et al.83  They have concluded  that MSAT is a 
simple, quick and sensitive test which can be used as a screening test for laboratories in 
developing countries.
In  this  study  the  highest  number  of  cases  were  in  the  21  –  30  years  age  group 
(23.71%)  followed  by  31  -  40  years  age  group  (19.87%)  (Table  2).  The  pattern  of  age 
distribution might be due to increased outdoor activity among the 21 – 30 years age group 
which increases chance of exposure to infection. In the study by Margarita R et al, the mean 
age affected was 36 years.50
There is very slight increase in the incidence in males (51.28%) compared to females 
(48.71%) ( Table 3) in this study. This  correlates with the Pappachan et al study in which 
58.9% were men.59
Higher incidence of leptospirosis occurs following rainfall.76,77 In this study, leptospirosis 
cases occurred throughout the year although the number increased  during the rainy season 
(Table 4). This may be due to the polluted environment which is an important epidemiological 
risk factor. This correlates with Sumathi G et al study (2004- 2006).84   In Sharma KK et al 
study*  the highest incidence of leptospirosis was during the rainy season.
In the present study the predominant symptoms were fever (100%), followed by high 
coloured  urine  (71.79%),  vomiting  (48.07%),  headache  (40.38%)(Table  5).  The  other 
symptoms were abdominal pain (34.61%), diarrhoea and cough (33.97%), myalgia (32.05%), 
breathlessness  (19.87%),  conjunctival  suffusion  (10.89%),  hemoptysis  (5.76%),  dysuria 
(8.33)%, oliguria (5.12%), altered sensorium and haematuria (4.48%). In Sritharan M et al 
study  all the patients had fever  with chills and myalgia (100%).81   In De A et al study fever 
was present in all cases (100%), myalgia in 51.35%, jaundice and conjunctival suffusion in 
32.43% and altered sensorium in 13.51% of patients.13 
In  the  study  conducted  by  MA  Muthusethupathy  et  al.(1995)  fever,  myalgia  and 
jaundice formed 100% followed by renal involvement in 77.7%, conjunctival suffusion 72.7%, 
gastrointestinal  symptoms  72%,  meningeal  signs  22.2%,  splenomegaly  5.5%  and 
haemorrhagic symptoms forming 3%.55
In  the study done by Margarita  R et  al(1999)  fever  constituted 100%, followed by 
headache 50%, epigastric pain 42%, jaundice  73% conjunctival suffusion  61.5%.50   
The  most  common  signs  observed  in  this  study  were  jaundice  (71.79%)  and 
hepatomegaly (32.69%) (Table 6). This is in accordance with Margarita R et al study in which 
jaundice was present in  70.2% and  hepatomegaly in 38.4% of patients.50  In Gancheva G et 
al  study  (2005)  hepatosplenomegaly  100%,  jaundice  75%,  hypotension  33.33%,  and 
haemorrhagic skin lesions 30.95%  were the common signs.27   In Marcial M R  et al study 
jaundice  70.2%,  oligoanuria  43.3%,  hepatomegaly  18.3%,  GI  bleeding 
17.3%,hematuria11.5% constitutes the predominant signs.49
The differences in distribution of major clinical features in this study might be due to 
the fact that the signs and symptoms keep varying from time to time as the infecting serovar 
also keeps changing with time
In  the  present  study out  of  the  156  samples  which  were  positive  by MSAT,  143 
(91.66%)  turned  positive  for  MAT  which  is  the  Gold  standard  method  (Table  7).  The 
predominant serovar were L.icterrohaemorrhagiae (49.65%) followed by L.australis (28.67%), 
L.semaranga  (13.28%),  L.grippotyphosa  (6.29%) and L.canicola  (1.92%) (Table 8).  Along 
with these serovars L.louisiana, L.autumnalis,  and L.hebdomadis were included in the panel 
but  these serovars were not causing leptospirosis in this study. In Sumathi G et al(2004 – 
2006)  study   L.icterrohaemorrhagiae  (48.0%)  was  the  predominant  serovar  followed  by 
L.australis  (37.0%)  and  L.grippotyphosa  (26.0%).84   In   the  study  by  Sritharan  et  al  in 
Hyderabad (2007), L.icterrohaemorrhagiae  was the predominant serovar (68%) followed by 
L.australis 22%,  L.autumnalis 8%,  L.javanica  2%.81   In  1995  the  study  conducted  by 
Leptospirosis Research Cell (LRC) revealed  L.autumnalis  as the common serovar84.  Now 
the  present  study  revealed  L.icterrohaemorrhagiae  as  the  predominant  serovar.   This 
indicates  the  seroprevalence   of  leptospirosis  in  different  periods  have  shown  various 
serogroups to be predominant.
In jaundice cases  L.icterrohaemorrhagiae  was found to be the predominant serovar .
(66.96%), followed by L.australis 21.42%, L.semaranga 9.82%. L.grippotyphosa 1.78% (Table 
9) in this study.  In Debnath C et al  (2004) study in jaundice cases L.pomona (80%) and 
L.grippotyphosa (20%) were the predominant serovar and none of the patients sera reacted 
against  L.  icterrohaemorrhagiae.14 The  seroprevalence  of  the  serovars  in  jaundiced 
leptospirosis patients was also studied by Joseph et al (1966) in Northern India. They found 
the prevalence of L.icterrohaemorrhagiae as 69.76%.36  
Other laboratory parameters were done for all patients in which ESR was raised in all 
cases (100%), followed by abnormal LFT in 71.79%, thrombocytopenia in 50.64%, abnormal 
RFT  in  26.92% and  both  abnormal  LFT   and  RFT  in  21.79% of  patients  (Table  10)..In 
Sritharan  M  et  al  study  abnormal  RFT  was  seen  in  52%  and  abnormal  LFT  in  44%of 
patients.81   In Gancheva et al study (2005) ESR was elevated in 86.90%, thrombocytopenia 
42.86%, abnormal RFT in 72.62%, abnormal LFT in 70.24%.27
White Blood Cell  count was normal  in 55.12% ,increased in 28.20%, decreased in 
16.66% of patients in the present study (Table11). This is in contrary to Marcial M.R. et al 
study in which White Blood Cell count was normal in 30.8% and leucocytosis in 69.2%.49   In 
Gancheva G et al*(2007) study leucocytosis was seen in 61.29%.28
Differential Count shows percentage of polymorphs were increased in 66.66% (Table 
12) of patients in the present study. In Gancheva G et al study polymorphs % were increased 
in 95.12%.28    
ESR was  moderately  raised  (less  than  50mm/hr)  in  75.64% and  extremely raised 
(more than 50mm/hr) in 24.35% (Table 13) in this study. This is in accordance with Gancheva 
G et al* (2007) study in which moderate rise in ESR was present in 74.39% and extreme rise 
in 20.73%.28
In  this  study  platelet  count  was  decreased  in  50.64%  of  patients  (Table  14).This 
correlates well  with the Gancheva G et al  (2007) study which shows thrombocytopenia in 
58.62%28 and  with Ramon Peces  study in which thrombocytopenia was seen in 58% of 
patients.69
Blood urea, serum creatinine were increased in 26.92% of cases (Table 15) in this 
study.  This is in contrary to Marcial M R et al study in which blood urea and serum creatinine 
were increased in 73.1% of patients49 and with  Margarita R et al study in which blood urea 
and serum creatinine were increased in 92.3% of patients.50
Only two cases (1.28%) out of 156 went in for Acute Renal Failure (Table 16). Both the 
cases after  appropriate  treatment  recovered.  No mortality was observed in  this  study.  In 
Margarita R et al study,  Acute renal failure was seen in 30.7%of patients.50  In Marcial M R et 
al study Acute Renal Failure was seen in 74%49 and in De A et al study it was seen in 16.2% 
of patients.13 In Muthusethupathi MA et al (1994) study in Madras city  during 1987-91 there 
were12054   cases of Acute Renal Failure due to leptospirosis,  but in the last two years there 
were only 15 cases of leptospiral ARF.53   In the present study there were only 2 cases.This 
indicates a decline in the severity of the disease and now more number of milder form of 
disease occurs.             
Blood urea, serum creatinine  were increased in  most patients of decreased platelet 
count (90.47%) than in patients with normal platelet count (9.52%) (Table 17). This correlates 
well  with  Ramon Peces  study in  which  it  was concluded  that  there exists  a  significant 
inverse correlation between platelet count and the renal parameters.69
There was an increase in SerumTotal bilirubin levels in 71.79% of patients (Table 18). 
This is in accordance with the Gancheva G et al (2007) study in which serum total bilirubin 
was increased in 75% of patients28 .and with Margarita R et al study in which it was increased 
in 73.6% of patients.50               
Serum total bilirubin level is usually <20mgm/dl in leptospirosis.70  This fact correlates 
with the present study in which serum Total bilirubin levels  were less than 20mgm/dl in all the 
cases  of  leptospirosis  except   in  a  patient  with  Hepatitis  B  coinfection.  The  serum total 
bilirubin level in this patient was 21.8mgm/dl. 
Serum Glutamic  Oxalo  Acetic  Transaminase  (SGOT)  were  normal  in  39.74% and 
increased in 60.24% of patients (Table 19) in this study. In Gancheva G et al (2007) study 
SGOT was normal in 23.17% and increased in 76.83%.28  In Margarita et al study  SGOT was 
elevated in 94% of patients.50
                 
Serum Glutamic Pyruvic Transaminase (SGPT) were normal in 36.53% and increased 
in  63.47% of  patients  (Table  20).  In  Gancheva  G et  al  (2007)  study 24.72% of  patients 
showed normal and 75.28% increased SGPT.28  In Margarita et al study SGPT was elevated 
in 94% of patients.50
           
In leptospirosis serum transaminases rarely exceed 200 IU/L* in contrast to acute viral 
hepatitis66. This fact correlates with the present study in which SGOT and SGPT were less 
than 200 IU/L in all the patients. 
 
Serum Alkaline Phosphatase (SAP) was normal in 42.30% and increased in 57.7% 
(Table 21). Gancheva G et al study showed normal SAP in 23.53% and increased SAP in 
76.47%.28  In Margarita et al study SAP was elevated in 61.5% of patients.50
In radiological parameter, X ray chest showed bilateral lower lobe opacity in 4 cases 
(2.56%) (Table 22). This indicates pulmonary involvement is rare in Chennai. In De A et al 
study pulmonary involvement  was seen in   37.83%13   and in Perani V et al study it was seen 
in 5.68%.64 
Dual  infection  of  leptospirosis  with  other  infections  have  been  reported.1,39,40, 
Leptospiral  illness  may  be  a  significant  component  in  cases  of  dual  infections  or  in 
simultaneous infections with more than two pathogens.3
In the present study dual infection with dengue was seen in 4 cases (2.56%) (Table 
23) as compared to 8% in Levett P. N. et al study in Barbados.47 All the four patients were 
positive for dengue IgM antibodies and had Acute primary dengue infection. Out of the 4 
patients , 2 were males and 2 were females, all in the age group of 20 – 30years. Fever 
(100%) and myalgia (75%) were  the predominant symptom in these patients. Splenomegaly 
in one patient (25%), hepatomegaly in one patient (25%) and haemorrhage in one patient 
(25%) were the signs observed in these patients (Table 24).. The characteristic dengue rash 
was absent in all these patients which is contrary to Levett P N et al study in Barbados in 
which all cases had dengue rash.47
In this study the differential count in dengue dual infection patients showed increased 
polymorphs  percentage  in  2  patients  (50%)  and  increased  lymphocytes  percentage  in  2 
patients (50%). Platelet count was normal in one patient (25%) and decreased in 3 patients 
(75%). Out of these three cases with decreased platelets, one had platelet count less than 
50,000  (Table  25),  which  indicates  poor  prognosis.  With  fluid   resuscitation,  platelet 
transfusion, appropriate drug and supportive therapy, patients recovered. No mortality was 
observed in these patients.
Concomitant  infection with Hepatitis B was seen in one patient (0.64%) (Table 23). No 
Indian  studies  have  been  reported  so  far  of  leptospirosis  with  concomitant  Hepatitis  B 
infection. In Singapore, Kaushik et al reported one case of Weil syndrome and concomitant 
Hepatitis B infection.40  In this study the patient was 30years old male,with symptoms of fever, 
headache,  myalgia,  vomiting  and  high  coloured  urine(Table  26).  Laboratory  parameters 
showed normal WBC count, polymorphs percentage increased, moderately raised ESR, renal 
parameters blood urea and serum creatinine increased. Serum total bilirubin, SGOT, SGPT, 
SAP were raised in this patient (Table 27).
In Kaushik et al study the patient was 30 years old male with complaints of epigastric 
pain,  fever,  chills  and  a  reduced  urine  output.   The  signs  observed  were  Jaundice, 
conjunctival  suffusion,  left  conjunctival  haemorrhage  and  flapping  tremor.  The  laboratory 
parameters  in  the  patient  showed  thrombocytopenia,  ,increased  blood  urea  and  serum 
creatinine and increased serum total bilirubin with elevated SGOT, SGPT, and SAP.40
In the present study the patient with Hepatitis B concomitant infection recovered fully 
from leptospirosis, despite the combined hepatic involvement by these two illnesses and with 
the severe systemic manifestations of leptospirosis,
All the patients in the present study recovered with appropriate drug and supportive 
therapy.  There was no mortality observed in this study .                               .
         Summary
SUMMARY
• The number of leptospirosis cases in this study was 156(41.26%).
• Incidence was higher in 21 to 30 years age group (23.71%)
• There was very slight preponderance in males (51.28%).
• Leptospirosis occured throughout the year although the number of cases increased after 
rainy season.
• The  most  common  symptoms  observed  were  fever(100%),  high  coloured 
urine(62.82%),vomiting (48.07%) and headache(40.38%).
• Jaundice was seen in 71.79% of patients.
• Out of the 156 samples positive by MSAT, 143 (91.66%)  were positive for Microscopic 
Agglutination Test (MAT).
• The  common  serovars  were  L.  icterohaemorrhagiae(49.65%),  followed  by  L. 
australis(28.64%),  L.  semaranga(13.28%),  L.grippotyphosa(6.29%),  and   L. 
canicola(1.92%).
• L.  icterohaemorrhagiae was  found  to  be  the  predominant  serovar  in  jaundice 
patients(66.96%).
• Elevated ESR was seen in all cases of leptospirosis, abnormal Liver Function Tests in 
71.79%, Thrombocytopenia in 50.64%, abnormal Renal Function Tests in 26.92%,both 
abnormal RFT and LFT in 21.79% of patients were observed.
• White  Blood  Cell  count  was  normal  in  55.12%  of  patients,  elevated  in  28.20%  and 
decreased in16.66% of patients.
• Differential Count showed polymorphs percentage were increased in 66.66% of patients.
• Moderate rise in ESR was seen in 75.64% of and extremely rised ESR in 24.35% of 
patients
• Blood urea, serum creatinine were raised in 26.92% of patients.
• 2 cases(1.28%) out of 156 went in for Acute Renal Failure.
• Blood  urea,  serum  creatinine  were  increased  in  more  number  of  thrombocytopenic 
patients(90.47%) compared to non-thrombocytopenic patients(9.52%).
• Serum total bilirubin was normal in 28.20% and elevated in 71.79% of patients.
• Serum total  bilirubin  was less than 20mgm/dl  in all  cases of  leptospirosis except  in  a 
patient with the Hepatitis B concomitant infection. The serum total bilirubin in this patient 
was 21.8mgm/dl.
• Serum  Glutamic  Oxalo  Acetic  transaminase  was  normal  in  39.74%  and  elevated  in 
60.25% of patients..
• Serum Glutamic Pyruvic transaminase was normal in 41.66% and elevated in 58.33% of 
patients..
• Serum Alkaline Phosphatase was normal in 42.30% and elevated in 57.69% of patients..
• Pulmonary involvement was seen in 4 cases (2.56%).
• Concomitant infection of leptospirosis with dengue were seen in 4 cases (2.56%) and with 
Hepatitis B in 1 case (0.64%).
• All the 4 cases of concomitant dengue infection had primary dengue.
• Fever (100%), and Myalgia (75%) were the predominant symptom in dengue concomitant 
infection patients.
• Thrombocytopenia was seen in 3 cases (75%) of dengue dual infection patient.
• Fever, headache, myalgia, vomiting, high coloured urine were the symptoms presented by 
the Hepatitis B concomitant infection patient.
• Normal total WBC count, increased polymorphs%, moderately elevated ESR, increased 
renal parameters, elevated serum total bilirubin with  raised SGOT,SGPT and SAP were 
observed in Hepatitis B dual infection patient.
• All the patients recovered with appropriate drug and supportive therapy. No mortality was 
observed in this study.
Conclusion       
CONCLUSION
• In conclusion, by correlating the biochemical  and haematological parameters a quick 
clinical  suspicion of  leptospirosis can be made out and diagnosed early,  for  initiating 
appropriate treatment.
•  The predominant serovar was L.icterrohaemorrhagiae (49.65%).
•  Concomitant  infection  of  leptospirosis  with  dengue  and  hepatitis  B  were  seen  and 
leptospirosis  should  not  be  missed  in  such  scenario  since  antimicrobial  agents  for 
leptospirosis can reduce its severity and duration.
• There was no mortality observed in this study due to early recognition and intensive 
treatment, even in the severe form of disease.
• Early  recognition  and  appropriate  treatment  leads  to  a  favourable  outcome  of  this 
potentially life threatening condition.
 Annexure       
PROFORMA
NAME:                   AGE:                          SEX:                   OCCUPATION:
IP No:                          ADDRESS:                                          DATE:
PRESENTING SYMPTOMS WITH DURATION:
PRESENTING SIGNS:
H/O PRESENT ILLNESS:
TREATMENT GIVEN:
INVESTIGATIONS:
1. Haematological parameters: Hb%
                                                    TC
                                                    DC
                                                    ESR
                                                    Platelet Count
2. Biochemical parameters:        LFT     
                                                   RFT
3. Radiological parameters:       Chest X- ray
                                                   Ultrasound Abdomen.
Abbreviations     
ABBREVIATIONS
DNA                               Deoxyribo Nucleic Acid
RNA                               Ribo Nucleic Acid
CSF                               Cerebro Spinal Fluid
MSAT                             Macroscopic Slide Agglutination Test
MAT                               Microscopic  Agglutination Test
ELISA                             Enzyme Linked Immunosorbent Assay.
HBsAg                            Hepatitis B Surface Antigen.
EMJH                             Ellinghausen – McCullough- Johnson-Harris 
LFT                                 Liver Function Tests
RFT                                Renal Function Tests
WBC                               White Blood Cells
ESR                                Erythrocyte Sedimentation Rate
SGOT                             Serum Glutamic Oxalo Acetic Transaminase
SGPT                             Serum Glutamic Pyruvic Transaminase
SAP                                Serum Alkaline Phosphatase
 
Appendices
APPENDIX – I
EMJH MEDIUM:
(Ellinughausen  –  Mccullough  –  Johnson  –  Harris  medium)  composition  of  EMJH 
medium base (Johnson Harris 1967).
.EMJH BASE-(DIFCO LABORATORIES, USA)
Ingredients gms/lit
Sodium phosphate diphasic      1
Potassium      3
Sodium chloride      1
Ammonium chloride    0.25
Thiamine   0.005
EMJH ENRICHMENT:
The enrichment bovine serum albumin (BSA) at the proportion of 1gm of BSA per 10 
ml of EMJH medium at a final concentration of 10%. It was then, filtered through a membrane 
(pore size .22µ) and was added as enrichment after cooling.
.
EMJH LIQUID MEDIUM:
Liquid EMJH medium was prepared by dissolving 2.3 gms of EMJH base in 900 ml of 
triple distilled water, the pH is adjusted to 7.5. After autoclaving at 15 lbs for 15 minutes the 
medium was added aseptically with enrichment at 10% level. 100ml of enrichment is added to 
900ml of EMJH medium. Later it was distributed aseptically in screw capped tubes. It was 
checked for sterility after 24 hrs at 27ºC
.EMJH SEMISOLID MEDIUM:
To prepare EMJH semisolid medium 0.2% bacteriological agar was added to the EMJH 
base and the complete medium was prepared as above.
SELECTIVE AGENT:
5-Fluoro  uracil  was  used  as  selective  agent.  Leptospira  are  resistant  to  the 
antibacterial activity of pyrimidine analogue,5-Fluora uracil.
100ml of 5FU was added to 5ml of distilled water. To this 0.1 to 0.2 ml of 0.1N NaOH 
was added and heated gently to dissolve 5-FU completely, The pH was adjusted t0 7.4 – 7.6 
and the volume was made upto  10ml  with  distilled  water.  The solution  was sterilised by 
filtration through membrane filter(pore size 0.45µm). Add 1 ml of this into 100ml of EMJH 
medium to get the final concentration of 100 µgm per ml. 
CULTURING OF LEPTOSPIRA:
Appropriate amount of organism was transferred to EMJH liquid and semisolid media. 
A period of 7 days incubation at room temperature (25-31ºC) was maintained. The culture 
was  then  examined  under  DFM to  check  for  the  required  growth  and  active  motility  of 
leptospira. Growth was also visualized as one or more rings, several mm below the surface of 
the semisolid medium. Once growth was found optimal, it was used as live antigen.
APPENDIX – II
REAGENTS:
1. Phosphate Buffered Saline (PBS):
Ingredients : g/l
Sodium chloride : 8.0
Potassium chloride : 0.2
Disodium hydrogen phosphate : 1.15
Potassium dihydrogen phosphate : 0.2
Distilled water : 1000 ml
pH was adjusted to 7.4.
The above ingredients were dissolved in sterile distilled water, and then filtered using 
filter paper 
APPENDIX – III
DENGUE IgM CAPTURE ELISA : (PANBIO)
PRINCIPLE:
• Serum  antibodies  of  IgM class  when  present  combine  with  antihuman  IgM 
antibodies attached to the polystyrene surface of the microwell test strips (assay 
plate).
• A concentrated pool of dengue 1 to 4 antigens is diluted to the correct working 
volume with antigen diluent.
• An equal volume of HRP conjugated monoclonal antibody (MAb) is added to the 
diluted antigen, which allows the formation of antigen-MAb complexes.
• Residual serum is removed from the assay plate by washing and complexed 
antigen-MAb is added to the assay plate.
• After incubation, the microwells are washed and a colourless substrate system 
tetramethylbenzidine/Hydrogen peroxide (TMB/H2O2) is added.
• The substrate is hydrolysed by the enzyme and the chromagen changes to a 
blue colour.
• After stopping the reaction with acid, The TMB becomes yellow.
• Colour development is indicative of the presence of anti dengue IgM antibodies 
in the test sample.
KIT COMPONENTS:
• Anti-human IgM coated microwells
• Dengue 1-4 antigens (Recombinant)
• Wash buffer concentrate
• Serum diluent
• Antigen diluent
• HRP conjugated monoclonal antibody tracer
• Tetramethyl benzidine TMB
• IgM positive control serum
• IgM cut off calibrator serum
• IgM negative control serum
• Stop solution
HBsAg ELISA: (HEPALISA)
KIT COMPONENTS:
• Microwells coated with anti- HBsAg (monoclonal)
• Enzyme Conjugate Concentrate.
• Conjugate Diluent.
• Wash Buffer Concentrate.
• TMB Concentrate.
• Substrate (TMB Diluent).
• Negative control serum
• Positive control serum.
• Stop solution.
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DENGUE IGM CAPTURE ELISA - TEST RESULT
A1-Positive control, B1-Negative control, C1,D1 and E1-cut off calibrator control
RAPID TEST KIT FOR DENGUE
Positive for Dengue IgM - Anti bodies
C-Control, M- IgM Antibodies, G-IgG Antiboides
HBS AG CAPTURE ELISA - TEST RESULTS
A1-Blank, B1 and C1-Negative Control, D1,E1 and F1-Positive Control
RAPID TEST KIT FOR HEPATITIS B
Positive  for HBs Ag.
